At least two of the p53 hotspot mutants R175H and R273H, which are well known cancer-derived gain-of-function p53 mutants accounting for 15% of all p53 mutations in cancer and have been shown to have crippling effects on knock-in mouse models [8, 48, 49]. Here, TP53 is linked to cancer.